A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
Clinical trial NCT04634409 · COMPLETED
Trial details
- NCT number
- NCT04634409
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2021-07-27
- Enrollment
- 1755
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.